Literature DB >> 12106744

Pseudophakic pupillary block caused by pupillary capture after phacoemulsification and in-the-bag AcrySof lens implantation.

Sudarshan Khokhar1, Harinder Singh Sethi, Parul Sony, Rajeev Sudan, Ambrish Soni.   

Abstract

We describe a 50-year-old patient who developed pupillary block caused by pupillary capture 1 week after uneventful phacoemulsification and implantation of an AcrySof foldable intraocular lens (IOL). The patient had a large but intact capsulorhexis with the haptics lying in the bag; the optic lay in the pupillary area anterior to the capsulorhexis. This case was successfully managed by a neodymium: YAG laser iridotomy, IOL explantation, and subsequent implantation of a poly(methyl methacrylate) posterior chamber IOL. To prevent this complication, we suggest the optic be larger than the capsulorhexis and advocate correct, gentle insertion of the foldable IOL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106744     DOI: 10.1016/s0886-3350(02)01305-6

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Long-term corneal endothelial cell changes in pediatric intraocular lens reposition and exchange cases.

Authors:  Yan Wang; Mingxing Wu; Liyuan Zhu; Yizhi Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-18       Impact factor: 3.117

2.  Interleukin-1β-induced Wnt5a enhances human corneal endothelial cell migration through regulation of Cdc42 and RhoA.

Authors:  Jeong Goo Lee; Martin Heur
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

3.  In office management of optic capture of scleral fixated posterior chamber intraocular lenses.

Authors:  Gregg T Kokame; Kevin Card; Alex U Pisig; Jessica G Shantha
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-26

4.  Rectangular loop suture to correct iris capture of the posterior chamber intraocular lens.

Authors:  Ke Lin; Zhixiang Hu; Zhong Lin; Tianyu Chen; Yongping Tang; Ronghan Wu
Journal:  BMC Ophthalmol       Date:  2020-09-25       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.